Skip to content

Use of Thermography for the Prevention and Diagnosis of Diabetic Foot

Use of Thermography for the Prevention and Diagnosis of Diabetic Foot

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06485362
Enrollment
100
Registered
2024-07-03
Start date
2024-09-01
Completion date
2026-09-01
Last updated
2024-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Angiopathy, Diabetic Foot, Diabetic Neuropathies

Keywords

diabetic foot, neuropaty, angiopaty, termography

Brief summary

Diabetic foot is a serious complication of diabetes mellitus that can lead to ulcerations, infections and, in extreme cases, amputations. Early detection of changes in skin temperature can help prevent these complications. Infrared thermography is a noninvasive technique that allows the visualization and quantification of skin temperature and could be an effective tool for the early detection of alterations in diabetic foot. Objective To evaluate the effectiveness of infrared thermography in the early detection and diagnosis of diabetic foot, comparing the temperatures of the feet of healthy subjects and subjects with diabetic foot.

Detailed description

Significant differences in foot temperatures are expected to be found between subjects with diabetic foot and healthy subjects. It is anticipated that areas of the foot at higher risk of ulceration in subjects with diabetic foot will show higher temperatures due to inflammation and changes in blood perfusion. The results of the study could validate the use of thermography as an early detection and monitoring tool in patients at risk of developing diabetic foot. This could allow early and personalized interventions to prevent serious complications.

Interventions

DIAGNOSTIC_TESTTermography

Thermographic images of both feet will be taken in multiple views (dorsal, plantar, lateral).

Sponsors

University of Seville
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

Subjects of both sexes. Age between 40 and 80 years. Diagnosis of type 1 or type 2 diabetes mellitus (for the case group). Absence of acute inflammatory diseases in the control group. Signed informed consent.

Exclusion criteria

Skin diseases that affect the interpretation of thermography. Recent treatment with medications that affect peripheral circulation. History of lower limb amputation.

Design outcomes

Primary

MeasureTime frameDescription
Temperature maximunOne measurement will be taken at the start of the study and another measurement the following year.Maximum foot temperatures
Temperature minimumOne measurement will be taken at the start of the study and another measurement the following year.Minimum foot temperatures

Countries

Spain

Contacts

Primary ContactRAQUEL GARCIA DE LA PEÑA, DOCTOR
raquelgp@us.es954486530
Backup ContactANA M RAYO PEREZ, DOCTOR
anarayo43@gmail.com661604278

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026